Hayward (HAYW) CEO Exercises Options at $1.40; Sells Shares at $15.72 Avg

Rhea-AI Filing Summary

Hayward Holdings, Inc. (HAYW) Form 4 summary: Kevin Holleran, listed as President, CEO and a director, reported transactions dated 09/03/2025. He exercised stock options to acquire 60,571 shares at an exercise price of $1.40 per share and simultaneously reported the acquisition of 60,571 shares. He also sold 60,571 shares in multiple transactions at a weighted average price of $15.7183 per share (range $15.59 to $15.8050). Following these transactions, the Form reports 2,696,284 shares beneficially owned with derivative holdings and 623,540 shares directly beneficially owned after the sale; three blocks of 700 shares are reported as indirectly owned by each of three children.

Positive

• Option exercise executed at $1.40, converting vested derivative rights into common shares
• Substantial retained stake: filing discloses 2,696,284 shares beneficially owned including derivatives

Negative

• Insider sale of 60,571 shares on 09/03/2025 at a weighted average price of $15.7183 may indicate partial monetization
• Sale executed in multiple transactions across a price range ($15.59 to $15.8050), requiring further breakdown for precise trade-level analysis

Insights

Securities Analyst

TL;DR: Insider exercised options, sold the same number of shares acquired, and retains substantial beneficial ownership.

Kevin Holleran exercised 60,571 options at $1.40 and sold 60,571 shares at a weighted average of $15.7183 on 09/03/2025. The filing discloses a remaining total beneficial position of 2,696,284 shares when including derivative holdings and direct ownership of 623,540 shares after the sale. The sale price range was disclosed as $15.59 to $15.8050 and the reporting person offers to provide breakdowns of quantities sold at each price upon request. These are routine Section 16 transactions showing option exercise liquidity and partial monetization without any additional disclosures of plans or changes in role.

Corporate Governance Expert

TL;DR: Transactions appear documented and comply with Form 4 reporting; no new governance events disclosed.

The filing is signed by an attorney-in-fact and includes the 10b5-1 plan checkbox indicating the transaction was made pursuant to a written plan. The Form shows both acquisition via option exercise and contemporaneous open-market sales of the same share count. The filing does not state any change in officer or director status and provides an explanation that sales occurred across a price range. No material corporate governance actions or departures are reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOLLERAN KEVIN

(Last) (First) (Middle)

HAYWARD HOLDINGS, INC.

1415 VANTAGE PARK DRIVE, SUITE 400

(Street)

CHARLOTTE NC 28203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hayward Holdings, Inc. [ HAYW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2025		M		60,571	A	$1.4	684,111	D
Common Stock	09/03/2025		S		60,571	D	$15.7183(1)	623,540	D
Common Stock								700	I	By Child A
Common Stock								700	I	By Child B
Common Stock								700	I	By Child C

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$1.4	09/03/2025		M			60,571	08/12/2021	12/24/2029	Common Stock	60,571	$0	2,696,284	D

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $15.59 to $15.8050, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

	/s/ Susan Canning, attorney-in-fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kevin Holleran report on the HAYW Form 4 filed for 09/03/2025?

He exercised 60,571 stock options at $1.40 per share, acquired 60,571 shares, and sold 60,571 shares at a weighted average price of $15.7183.

How many shares does Kevin Holleran beneficially own after the reported transactions?

The filing reports 2,696,284 shares beneficially owned including derivative holdings and 623,540 shares directly beneficially owned following the sale.

Were the sales executed under a trading plan for HAYW insider transactions?

Yes. The Form 4 has the box checked indicating the transaction was made pursuant to a contract, instruction or written plan intended to satisfy Rule 10b5-1(c).

What price range did the Form 4 disclose for the sold HAYW shares?

The shares were sold in multiple transactions at prices ranging from $15.59 to $15.8050; the weighted average reported is $15.7183.

Who signed the Form 4 filing for Kevin Holleran?

The filing is signed by Susan Canning as attorney-in-fact on 09/04/2025.